BTIG analyst Thomas Shrader raised the price target on Bright Minds Biosciences Inc. (NASDAQ: DRUG) to $147.00 (from $72.00) while ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE